Douglas B. Snyder — Chief Legal Officer at GW Pharmaceuticals

Mr. Douglas B. Snyder, also known as Doug, has been Chief Legal Officer at GW Pharmaceuticals plc since July 2017. Mr. Snyder served as Vice President, General Counsel and Secretary of Eisai Inc. since August 2005, Where he led the Legal, Compliance, Legislative Affairs, Internal Audit and Security Group. Mr. Snyder served as Senior Vice President, General Counsel and Secretary of Actelion Pharmaceuticals US, Inc. He was associated with GlaxoSmithKline (GSK) where he served as Vice President and Associate General Counsel from 1999 to 2005. His responsibilities included legal services for sales and marketing, research and development, manufacturing and other functions as well as management of litigation, contract and regulatory activities. Prior to GlaxoSmithKline Pharmaceuticals, he was associate chief counsel at the U.S. Food & Drug Administration (FDA), working with the FDA Commissioner, the Center for Drug Evaluation and Research and congressional and other government officials on legislative and regulatory issues. He has more than 20 years of experience providing counsel in the pharmaceutical industry, at the Food and Drug Administration (FDA) and in private practice. Mr. Snyder holds a J.D. from the Catholic University of America, Columbus School of Law and a B.A. from Dickinson College.